Physiotherapist Reports Positive Pain Management Effects of Magcell Arthro for Osteoarthritis


Please share this content...
         

Physiotherapist Reports Positive Pain Management Effects of Magcell Arthro for Osteoarthritis

Back to overview


Tel: +44 (0)115 9167685


"In May 2018, at the Acupuncture Association for Chartered Physiotherapists (AACP) Annual Conference I enquired about the Magcell Arthro device, Mary gave me a demonstration to see if would help with my osteoarthritic pain...

After just 5 minutes I felt relief, too good to be true I thought! So I gave it a few days, the relief was excellent.  After a week, the pain started to get back to the same level prior to the short treatment I had received. After calling the office, I purchased the Magcell Arthro from Physiopod and for more than 10 months, I have used the device and have been so pleased with the ease it brings me. 

I am finding it helps with the pain in my thumbs and right knee, so much so that I am off all pain meds. This small device can be transported with ease and used in meetings without being detected or disturbing the meeting. All in all, this is a wonderful device. Thank you!

 paul battersby

Paul Battersby

MCSP. MSc. BSc. (HONS)

MAGCELL® ARTHRO

Pain-alleviating and movement-promoting effect for osteoarthritis

MAGCELL® ARTHRO

MAGCELL® ARTHRO significantly improves general symptoms (WOMAC total score) and individual scores for pain, stiffness and daily activity in osteoarthritis (ARC criteria II and III). The therapy can be applied several times daily as a complementary treatment without side effects and may thus help to reduce intake of pain medication. 

  • Electrode-free electrotherapy for therapists and patients
  • Pulsating electromagnetic fields (PEMF)
  • Field strength more than 1000 gauss
  • Effective treatment concept due to repeatable short-treatment periods
  • Through-textile treatment (even through shoes)

 


 

GENERAL FEATURES

  • Very easy one-button operation
  • Battery-driven
  • Optical and acoustic function control
  • Automatic switch-off at the end of the therapy period
  • 1 In a randomised controlled study on the effect of MAGCELL® ARTHRO for knee arthritis with osteoarthritis level 2.8±0.8 (American College of Rheumatology criteria) at the primary clinical end point (WOMAC total score) median increase of 0.7 P (non-significant) was recorded in the placebo group between T0 and T1 (18 days), yet in the MAGCELL®-group a significant local decrease of 21.8 P. During the study no undesirable incidents or side effects occurred related to therapy.
  • 2 The WOMAC individual scores for pain, stiffness and daily activity also resulted in significant local improvements in the MAGCELL®-group compared to a slight median increase (non-significant) in the placebo group. A highly significant result (p < 0.001) in favour of the MAGCELL®-group was recorded for the individual parameter pain reduction compared to the placebo in the difference between the beginning and end of treatment.
  • MAGCELL® is utilised for pain alleviation and movement stimulation in the case of osteoarthritis
  •  
 
Leaflet MAGCELL® ARTHRO 
Leaflet MAGCELL® ARTHRO 

Brochure

Magcell Athro Patient Brochure
General catalogue "Physical Therapy" 
General catalogue "Physical Therapy"

 

Studies

Funk H.W., Knels L., Augstein A., Marquetant R., Dertinger H.F. (2014): Potent Stimulation of Blood Flow of Volunteers after Local Short-Term Treatment with Low-Frequency Magnetic Fields from a Novel Device. Evidence-Based Complementary and Alternative Medicine 2014. Article ID 543564, 9 pages. http://dx.doi.org/10.1155/2014/543564.

Funk R.H.W. (2018): Coupling of pulsed electromagnetic fields (PEMF) therapy to molecular grounds of the cell. Am J Transl Res 10(5):1260-1272. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992548.

Geiger G., Mikus E., Dertinger H., Rick O. (2015): Low frequency magnetic field therapy in patients with cytostatic-induced polyneuropathy: A phase II pilot study. Bioelectromagnetics 36(3): 251-254. doi: 10.1002/bem.21897.

Hitrov N.A., Portnov V.V. (2008): MAGCELL® ARTHRO in der Behandlung von Arthrose im Kniegelenk. Die Naturheilkunde 3, 25-27.

Leoci R., Aiudi G., Silvestre F., Lissner E., Lacalandra G.M. (2014): Effect of Pulsed Electromagnetic Field Therapy on Prostate Volume and Vascularity in the Traetment of Benign Prostatic Hyperplasia: A Pilot Study in a Canine Model. The Prostate 74: 1132-1141.

Reimschüssel A., Bodenburg P. (2009): Niederfrequente elektromagnetische Felder. Erfolgreich in der Therapie der Myoarthritis des Kiefergelenkes. Die Naturheilkunde 5, 28.

Rick O., von Hehn U., Mikus E., Dertinger H., Geiger G. (2017): Magnetic Field Therapy in Patients With Cytostatics-Induced Polyneuropathy: A Prospective Randomized Placebo-Controlled Phase-III Study. Bioelectromagnetics 38(2): 85-94:. doi: 10.1002/bem.22005.

Wuschech H., von Hehn U., Mikus E., Funk R.H. (2015): Effects of PEMF on patients with osteoarthritis: Results of a prospective, placebo-controlled, double-blind study. Bioelectromagnetics 36(8), 576–585.

 


TECHNICAL DATA
  • Protection class: Internal power supply
  • Power supply: 2 x 1.5 V R6 alkaline batteries
  • Magnetic field strength max: 200 mT 
  • Treatment duration MAGCELL® ARTHRO 2.5 min. 
  • Dimensions (W x H x D): 83 x 152 x 25 mm 
  • Weight: 0.21 kg